To determine how our observations of cutaneous involvement in pristane-treated Ogg1−/− mice translated to human SLE, we looked at potential clinical associations of OGG1 expression in our SLE patient cohort (21). This evidence concerns the gene OGG1 and systemic lupus erythematosus.